What is the medical insurance reimbursement price for clofazimine?

Clofazimine (Clofazimine) is a drug mainly used to treat leprosy and was developed by the Swiss company Novartis. It is a red dye compound that was first synthesized in 1957 and began to be used for clinical treatment in the 1960s.

The anti-leprosy effect of clofazimine is mainly achieved by inhibiting the growth of Mycobacterium leprae. It inhibits bacterial growth and reproduction by binding to bacterial DNA and interfering with its replication and transcription processes. In addition, clofazimine also has anti-inflammatory effects and can reduce the inflammatory symptoms of patients in the reactive phase of leprosy.

Clofazimine has relatively few side effects, but some adverse reactions may occur during long-term use. Common side effects include red staining of the skin and eyes, dry and flaky skin, gastrointestinal upset (such as nausea, vomiting, diarrhea). In rare cases, more serious side effects may occur, such as abnormal liver function, intestinal obstruction, and visual impairment. Therefore, during treatment with clofazimine, patients should undergo regular liver function and ophthalmological examinations to monitor for possible adverse reactions.

Clofazimine is currently on the market in China and has been included in medical insurance. Patients can purchase it at pharmacies of major hospitals in the country. After being included in medical insurance, the price of clofazimine is around a few hundred yuan. The specific price and medical insurance reimbursement vary by region. Patients can consult the local hospital pharmacy for detailed information. After reimbursement from medical insurance, the patient's out-of-pocket payment will be greatly reduced, reducing the financial burden. The cheaper ones abroad are Indian generic drugs. The price of 100mg*100 tablets is around 500 to 600, which is much cheaper than in China.

Clofazimine is an effective anti-leprosy drug. Although it has some side effects, its importance in the treatment of leprosy cannot be ignored. Through rational use of medication and standardized treatment, clofazimine can significantly improve the quality of life of leprosy patients and help them recover from health. Domestic clofazimine has been included in medical insurance, reducing the financial burden on patients and providing wider drug accessibility.